ArticleEuropean journal of radiology open2026
DCE-MRI and Mammography integrated radiomic analysis in triple negative ductal invasive breast cancer patients. Comparison between BRCA and not BRCA mutated patients: preliminary results.
Article in European journal of radiology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We propose a combined radiomic model based on features extracted from DCE-MRI and mammographic images (MG) to discriminate the mutational status of BRCA genes in patients with TNBC. Material and methods: This retrospective study included patients histologically diagnosed with TNBC who performed a mammography followed by a DCE-MRI between 2010 and 2021.A manual segmentation was performed on the entire tumor volume on both imaging modalities. Subsequently, a 5-mm ROI was placed within the segmented tumor volume and the contralateral healthy gland. Radiomic features were extracted from these ROIs using Pyradiomics and selected with Maximum Relevance Minimum Redundancy algorithm to fit different classifiers.A final model was developed by integrating the most predictive features extracted from lesion and healthy gland from both modalities into a single multivariate framework. Finally, the added value of an integrated approach was assessed by comparing the performance with single-modality radiomic models. Results: The population included 52 patients for a total of 53 lesions (13 BRCA-mutated, 40 non BRCA-carriers). The highest classification performance for BRCA mutational status was achieved by Random Forest that integrated both MRI and mammography features, yielding an Area Under the Curve (AUC) of 0.91. Most predictive features were extracted from healthy gland regions and from MR wash-in/wash-out maps. Multimodal imaging analysis outperformed the best models of single-modality approaches (AUC Conclusions: This study reinforces the feasibility of radiomics to predict BRCA mutation in patients with TNBC, highlighting the possibility of integrating different imaging modalities to enhance model accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.